Colaianne, 2025 - Google Patents
Statistical Considerations in the Design of Clinical TrialsColaianne, 2025
View PDF- Document ID
- 3694505813243210312
- Author
- Colaianne J
- Publication year
External Links
Snippet
The design of clinical trials is a very broad topic encompassing virtually all of the statistical concepts of good experimental design as applied in medical research. This discussion will only attempt to provide a general review of the major concepts, particularly as they apply in …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/324—Management of patient independent data, e.g. medical references in digital format
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
- G06F19/363—Manual data input, e.g. electronic questionnaires or clinical trials
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ng et al. | The effect of dexmedetomidine on delirium and agitation in patients in intensive care: systematic review and meta‐analysis with trial sequential analysis | |
| Gamez et al. | Predicting severity of acute pain after cesarean delivery: a narrative review | |
| Garber et al. | Continuous infusion ketamine for adjunctive analgosedation in mechanically ventilated, critically ill patients | |
| Moretto et al. | Interventions for treating persistent and intractable hiccups in adults | |
| Burchiel et al. | Prognostic factors of spinal cord stimulation for chronic back and leg pain | |
| Shiel et al. | The effects of increased rehabilitation therapy after brain injury: results of a prospective controlled trial | |
| McLELLAN et al. | Is the counselor an “active ingredient” in substance abuse rehabilitation?: an examination of treatment success among four counselors | |
| Cepeda et al. | Cochrane Review: Adjusting the pH of lidocaine for reducing pain on injection | |
| Mattick et al. | Buprenorphine versus methadone maintenance therapy: a randomized double‐blind trial with 405 opioid‐dependent patients | |
| Hill et al. | Interventions designed to limit gestational weight gain: a systematic review of theory and meta‐analysis of intervention components | |
| Boldt et al. | Non‐pharmacological interventions for chronic pain in people with spinal cord injury | |
| Rosenthal et al. | Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone | |
| Irvin et al. | The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trials | |
| Naci et al. | Timing and characteristics of cumulative evidence available on novel therapeutic agents receiving Food and Drug Administration accelerated approval | |
| Olson et al. | Psychological variables associated with outcome of spinal cord stimulation trials | |
| Bienhoff et al. | Efficacy and safety of deracoxib for control of postoperative pain and inflammation associated with soft tissue surgery in dogs | |
| Hansen et al. | Associations between psychological variables and pain in experimental pain models. A systematic review | |
| Ingram et al. | Hemilaminectomy for thoracolumbar Hansen Type I intervertebral disk disease in ambulatory dogs with or without neurologic deficits: 39 cases (2008–2010) | |
| Wodlin et al. | Health‐related quality of life and postoperative recovery in fast‐track hysterectomy | |
| Boeuf et al. | Naloxone for shock | |
| Ferré-Dolcet et al. | Disappearance of signs of heat and induction of ovulation in oestrous queens with gonadorelin: a clinical study | |
| Bridgman et al. | Practical aspects of randomization and blinding in randomized clinical trials | |
| Chang et al. | Joint‐Specific Memory and Sustained Risk for New Joint Accumulation in Autoimmune Arthritis | |
| Chavkin et al. | Donor sperm insemination cycles: are two inseminations better than one? | |
| Helgeson et al. | Retrospective review of diphenhydramine versus diphenhydramine plus glucocorticoid for treatment of uncomplicated allergic reaction in dogs |